US Stock MarketDetailed Quotes

ARCT Arcturus Therapeutics

Watchlist
  • 11.970
  • +0.020+0.17%
Trading Mar 27 13:48 ET
324.62MMarket Cap-3.99P/E (TTM)

About Arcturus Therapeutics Company

Arcturus Therapeutics Holdings, Inc. operates as a late-stage clinical mRNA medicines and vaccine company, which engages in the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. Its products include LUNAR-COV19, LUNAR-FLU, LUNAR-OTC, and LUNAR-CF. The company was founded in 2013 and is headquartered in San Diego, CA.

Company Profile

SymbolARCT
Company NameArcturus Therapeutics
Listing DateMay 22, 2013
Founded2013
CEOMr. Joseph E. Payne
MarketNASDAQ
Employees176
Fiscal Year Ends12-31
Address10628 Science Center Drive,Suite 250
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92121
Phone1-858-900-2660

Company Executives

  • Name
  • Position
  • Salary
  • Joseph E. Payne
  • Director, President and Chief Executive Officer
  • 4.89M
  • Lance Kurata
  • Chief Legal Officer
  • 2.10M
  • Dr. Padmanabh Chivukula
  • Chief Scientific Officer and Chief Operating Officer
  • 3.18M
  • Andrew H. Sassine
  • Director, Chief Financial Officer and Principal Accounting Officer
  • 2.18M
  • Dr. Moncef M. Slaoui, PhD
  • Chairman of the Board
  • --
  • James F. Barlow
  • Independent Director
  • 330.50K
  • Dr. Peter C. Farrell, A.M.,PhD
  • Independent Director
  • 328.00K
  • Dr. Magda Marquet, PhD
  • Independent Director
  • 318.00K
  • Dr. John H. Markels, PhD
  • Independent Director
  • 320.50K
  • Dr. Jing L. Marantz, M.D.,PhD
  • Independent Director
  • 318.00K
  • Dr. Edward W. Holmes
  • Independent Director
  • 325.50K
  • Joseph Robert
  • Controller
  • --

Market Insights

Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Unlock Now
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More